Nuzenio

Sionna

Sionna news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 18 publisher sources 100/100 entity strength

Latest news

Guggenheim Reiterates Neutral Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeatMarketBeat · Mon, 10 Aug 2026 18:14:23 GMTApple, Sionna, AbCellera, Sandisk, SpaceX, Berkshire, and More Stocks That Explain Today’s Market - Barron'sBarron's · Mon, 10 Aug 2026 17:49:00 GMTSionna Therapeutics (NASDAQ:SION) Drops 92% After Failed Study, Shares Fall Below Gross Cash - TechStock²TechStock² · Mon, 10 Aug 2026 16:59:28 GMTSionna Therapeutics stock plunges nearly 100% after cystic fibrosis drug fails key trial - The Business JournalsThe Business Journals · Mon, 10 Aug 2026 16:58:00 GMTSionna's lead cystic fibrosis program fails Phase IIa test, clouding NBD1 stabilizer strategy - AllSciAllSci · Mon, 10 Aug 2026 16:49:36 GMTSionna cystic fibrosis drug fails key trial, removing threat to Vertex - BioPharma DiveBioPharma Dive · Mon, 10 Aug 2026 16:27:14 GMTVertex's would-be rival Sionna scraps cystic fibrosis drug add-on after trial flop - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 16:12:18 GMTSionna Therapeutics' (SION) "Neutral" Rating Reiterated at Wedbush - MarketBeatMarketBeat · Mon, 10 Aug 2026 16:10:28 GMT

Timeline

Mon, 10 Aug 2026 18:14:23 GMTGuggenheim Reiterates Neutral Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeat
Mon, 10 Aug 2026 17:49:00 GMTApple, Sionna, AbCellera, Sandisk, SpaceX, Berkshire, and More Stocks That Explain Today’s Market - Barron's
Mon, 10 Aug 2026 16:59:28 GMTSionna Therapeutics (NASDAQ:SION) Drops 92% After Failed Study, Shares Fall Below Gross Cash - TechStock²
Mon, 10 Aug 2026 16:58:00 GMTSionna Therapeutics stock plunges nearly 100% after cystic fibrosis drug fails key trial - The Business Journals
Mon, 10 Aug 2026 16:49:36 GMTSionna's lead cystic fibrosis program fails Phase IIa test, clouding NBD1 stabilizer strategy - AllSci
Mon, 10 Aug 2026 16:27:14 GMTSionna cystic fibrosis drug fails key trial, removing threat to Vertex - BioPharma Dive

Related explainers

EconomyEconomy stories explain how money, jobs, prices, policy, trade, and business confidence affect daily life.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Sionna.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

18 distinct publisher/source names are currently connected to this entity page.